by Bill Snyder
Craig Lindsley, PhD, a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is being honored by the American Society for Pharmacology and Experimental Therapeutics (ASPET) for his transformative approaches to identifying potential new drugs.
Lindsley, director of medicinal chemistry in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), will receive the inaugural Scientific Achievement Award in Drug Discovery and Development during the ASPET Annual Meeting in Orlando, Florida, in April.
Lindsley is the William K. Warren Jr. Professor of Medicine, University Professor of Pharmacology and Biochemistry in the School of Medicine and University Professor of Chemistry in the College of Arts and Science.
The award recognizes his highly integrated approach bridging synthetic chemistry, novel pharmacokinetic/pharmacodynamic modeling and target validation that has led to pre-clinical development of potential therapeutics for neurological disorders, cancer and metabolic diseases.
A fellow of the American Association for the Advancement of Science (AAAS), Lindsley has received several honors for his research including ASPET’s John J. Abel Award in Pharmacology for young investigators in 2014, the ASPET-Astellas Award for Translational Pharmacology in 2010, and the Pharmacia-ASPET Award in Experimental Therapeutics in 2017.
